TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.58
-1.86 (-2.64%)
At close: Mar 28, 2025, 4:00 PM
68.20
-0.38 (-0.55%)
After-hours: Mar 28, 2025, 7:56 PM EDT

TransMedics Group Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 118.44, with a low estimate of 75 and a high estimate of 178. The average target predicts an increase of 72.70% from the current stock price of 68.58.

Analyst Consensus: Buy
Target Low Average Median High
Price $75 $118.44 $120 $178
Change +9.36% +72.70% +74.98% +159.55%

Analyst Ratings

The average analyst rating for TransMedics Group stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 333333
Buy 654444
Hold 234443
Sell 000000
Strong Sell 000000
Total 111111111110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Needham
Needham
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Mar 26, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$104
Strong Buy Maintains $104 +51.65% Mar 11, 2025
Needham
Needham
Hold
Reiterates
n/a
Hold Reiterates n/a n/a Feb 5, 2025
JP Morgan
JP Morgan
Hold
Downgrades
$116$75
Hold Downgrades $116$75 +9.36% Dec 17, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$110$90
Buy Maintains $110$90 +31.23% Dec 11, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
552.99M
from 441.54M
Increased by 25.24%
Revenue Next Year
662.99M
from 552.99M
Increased by 19.89%
EPS This Year
1.49
from 1.01
Increased by 47.95%
EPS Next Year
2.29
from 1.49
Increased by 53.50%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
25.64M30.26M93.46M241.62M441.54M552.99M662.99M760.31M
Revenue Growth
8.62%18.03%208.83%158.53%82.74%25.24%19.89%14.68%
EPS
-1.16-1.60-1.23-0.771.011.492.293.02
EPS Growth
-----47.95%53.50%31.69%
Forward PE
-----45.8929.9022.70
No. Analysts -----13129
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 603.0M 720.8M 871.5M
Avg 553.0M 663.0M 760.3M
Low 498.5M 594.8M 538.4M

Revenue Growth

Revenue Growth 20252026202720282029
High
36.6%
30.4%
31.4%
Avg
25.2%
19.9%
14.7%
Low
12.9%
7.6%
-18.8%

EPS Forecast

EPS 202520262027
High 1.89 3.14 4.20
Avg 1.49 2.29 3.02
Low 1.23 1.53 2.36

EPS Growth

EPS Growth 202520262027
High
87.1%
110.1%
83.1%
Avg
48.0%
53.5%
31.7%
Low
22.3%
2.3%
3.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.